CHRISTINA OUELLETTE: Open Payments
NPI 1124491006 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 23 payments from 7 companies in 2025. Trend: 2023 $209 · 2024 $156 · 2025 $949
Food & beverage: $837Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $525 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $112 |
| ABBVIE INC. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: AUSTEDO XR, UZEDY, Auvelity, INGREZZA, VRAYLAR, CAPLYTA, Qelbree, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
